High-Risk Prostate Cancer: Local Therapy Matters

被引:0
|
作者
Liss, Adam L. [1 ]
Hamstra, Daniel A. [1 ]
机构
[1] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
关键词
combination brachytherapy; high-risk prostate cancer; local control;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent years, a large focus of the management of prostate cancer has been to de-intensify treatment. Strategies to reduce treatment include decreasing the number of radiation treatment (RT) sessions, omitting surgery or RT altogether for men not expected to die of prostate cancer, and eliminating PSA screening completely. These could be effective strategies to decrease overtreatment, reduce the adverse effects of screening and treatment, and ultimately help to decrease the cost of medical care. There remains a population of men, however, who are diagnosed with more aggressive, locally advanced prostate cancer for which the standard treatment options are lacking and intensification of treatment is needed. This review summarizes treatment options for men with high-risk prostate cancer, including radical prostatectomy, external-beam radiotherapy (EBRT), and androgen-deprivation therapy (ADT). The focus here, however, will be on examining strategies to improve outcomes though intensification of local therapy using a combination of brachytherapy, EBRT, and ADT.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 50 条
  • [1] High-risk prostate cancer: the role of radical prostatectomy for local therapy
    Ghavamian, Reza
    Williams, Steve K.
    Hakimi, A. Ari
    [J]. FUTURE ONCOLOGY, 2011, 7 (04) : 543 - 550
  • [2] High-risk prostate cancer—classification and therapy
    Albert J. Chang
    Karen A. Autio
    Mack Roach
    Howard I. Scher
    [J]. Nature Reviews Clinical Oncology, 2014, 11 : 308 - 323
  • [3] Adjuvant Therapy in High-Risk Prostate Cancer
    Shevach, Jeffrey
    Chaudhuri, Parul
    Morgans, Alicia K.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 45 - 53
  • [4] Neoadjuvant Therapy in High-Risk Prostate Cancer
    Ashrafi, Akbar N.
    Yip, Wesley
    Aron, Monish
    [J]. INDIAN JOURNAL OF UROLOGY, 2020, 36 (04) : 251 - 261
  • [5] Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches
    Syed, S
    Petrylak, DP
    Thompson, IM
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (03) : 235 - 243
  • [6] Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
    Zaorsky, Nicholas G.
    Spratt, Daniel E.
    Kishan, Amar U.
    Culp, Stephen H.
    Showalter, Timothy N.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [7] Proton Therapy in the Management of High-Risk Prostate Cancer
    Bryant, C. M.
    Henderson, R. H.
    Hoppe, B. S.
    Mendenhall, W. M.
    Nichols, R.
    Su, Z.
    Li, Z.
    Williams, C. R.
    Morris, C. G.
    Mendenhall, N. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S420 - S420
  • [8] Neoadjuvant therapy for high-risk localized prostate cancer
    Evan Y. Yu
    William K. Oh
    [J]. Current Oncology Reports, 2003, 5 (3) : 250 - 257
  • [9] Androgen Deprivation Therapy in High-Risk Prostate Cancer
    Buyyounouski, Mark K.
    [J]. ONCOLOGY-NEW YORK, 2010, 24 (09): : 806 - 809
  • [10] High-risk prostate cancer-classification and therapy
    Chang, Albert J.
    Autio, Karen A.
    Roach, Mack, III
    Scher, Howard I.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2014, 11 (06) : 308 - 323